WeVote
Log In

Bill

Bill

H 1346

An Act to improve sickle cell care

194th Legislature (2025-2026) Introduced by Dave Rogers and 1 co-sponsor

Massachusetts bill H.1346 expands sickle cell disease care and support services to improve patient access to treatment and reduce health disparities among affected populations.

Accompanied a new draft, see H4554
0
WeVote Research Nonpartisan
Bill Summary · H 1346

Legislative bill overview

H.1346 is a Massachusetts bill designed to enhance sickle cell disease care and support services across the state. The bill was referred to the Committee on Financial Services, suggesting it likely includes funding mechanisms or insurance-related provisions to improve access to treatment, screening, or patient support programs for individuals with sickle cell disease.

Why is this important

Sickle cell disease disproportionately affects African American and other minority populations, and many patients face barriers to comprehensive care, including limited access to specialists and high treatment costs. Improving care infrastructure and coverage could reduce complications, hospitalizations, and mortality rates while addressing significant health disparities in Massachusetts.

Potential points of contention

  • Funding and costs: Questions about how the bill's provisions will be funded, whether through state budget allocations, insurance premium adjustments, or federal matching funds
  • Insurance coverage specifics: Debate over what treatments, screenings, or services should be mandated coverage under different insurance plans and associated affordability implications
  • Implementation timeline: Concerns about whether healthcare providers and systems have adequate capacity and training to expand sickle cell services without overwhelming existing resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.